Pacific Biosciences Of California | PACB - Assets


Pacific Biosciences Of California reported $782.36M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Danaher USD 92.37B 8.82B Jun/2026
General Electric Aerospace USD 127.67B 773M Jun/2026
Illumina USD 6.65B 91M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Waters USD 24.53B 19.45B Mar/2026